The $9 billion Silicon Valley startup aims to give patients control over their health.
Friday, July 3, 2015
Why it's all about the Model X for Tesla
July 2 -- Bloomberg Intelligence's Kevin Tynan discusses Tesla beating its car-sales forecast for the second consecutive quarter. He speaks with Bloomberg's Cory Johnson and Matt Miller on "Bloomberg West."
Subscribe to:
Posts (Atom)
